These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 15742545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM, Bruns GL, Todd BL, Feuerstein M.
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [Abstract] [Full Text] [Related]

  • 3. Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study.
    Debess J, Riis JØ, Engebjerg MC, Ewertz M.
    Breast Cancer Res Treat; 2010 May; 121(1):91-100. PubMed ID: 20306129
    [Abstract] [Full Text] [Related]

  • 4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Gundy C, Schagen SB.
    J Clin Oncol; 2012 Apr 01; 30(10):1080-6. PubMed ID: 22370315
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM.
    Psychooncology; 2006 May 01; 15(5):422-30. PubMed ID: 16097037
    [Abstract] [Full Text] [Related]

  • 7. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL.
    Breast Cancer Res Treat; 2010 Aug 01; 123(1):25-34. PubMed ID: 19894112
    [Abstract] [Full Text] [Related]

  • 8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U.
    Patient Educ Couns; 2007 Apr 01; 66(1):108-18. PubMed ID: 17320337
    [Abstract] [Full Text] [Related]

  • 9. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH, Dy CJ, Castellon SA, Lai J, Pio BS, Abraham L, Waddell K, Petersen L, Phelps ME, Ganz PA.
    Breast Cancer Res Treat; 2007 Jul 01; 103(3):303-11. PubMed ID: 17009108
    [Abstract] [Full Text] [Related]

  • 10. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
    Prokasheva S, Faran Y, Cwikel J, Geffen DB.
    J Psychosoc Oncol; 2011 Jul 01; 29(5):499-514. PubMed ID: 21882931
    [Abstract] [Full Text] [Related]

  • 11. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.
    Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS.
    Breast Cancer Res Treat; 2005 Nov 01; 94(1):53-61. PubMed ID: 16175317
    [Abstract] [Full Text] [Related]

  • 12. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA.
    Brain Cogn; 2005 Oct 01; 59(1):60-70. PubMed ID: 15975700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C, Savard J, Ivers H.
    Breast Cancer Res Treat; 2009 Jul 01; 116(1):113-23. PubMed ID: 18629633
    [Abstract] [Full Text] [Related]

  • 16. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
    Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, Beex LV, Van Dam FS, Schagen SB.
    Acta Oncol; 2009 Jul 01; 48(1):76-85. PubMed ID: 18777410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Aug 01; 18(8):811-21. PubMed ID: 19085975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.